TY - JOUR
T1 - Inequalities in Financial Distress, Symptoms, and Quality of Life Among Patients with Advanced Cancer in France and the U.S.
AU - Barbaret, Cécile
AU - Delgado-Guay, Marvin O.
AU - Sanchez, Stéphane
AU - Brosse, Christelle
AU - Ruer, Murielle
AU - Rhondali, Wadih
AU - Monsarrat, Léa
AU - Michaud, Patrick
AU - Schott, Anne Marie
AU - Bruera, Eduardo
AU - Filbet, Marilène
N1 - Publisher Copyright:
© AlphaMed Press 2019
PY - 2019
Y1 - 2019
N2 - Background: Financial distress (FD) is common among patients with advanced cancer. Our purpose was to compare the frequency and intensity of FD and its associations with symptom distress and quality of life (QOL) in these patients in France and the U.S. Materials and Methods: In this secondary analysis of two cross-sectional studies, we assessed data on 292 patients who received cancer care at a public hospital or a comprehensive cancer center in France (143 patients) or the U.S. (149 patients). Outpatients and hospitalized patients over 18 years of age with advanced lung or breast or colorectal or prostate cancer were included. Diagnosed cognitive disorder was considered a noninclusion criterion. Advanced cancer included relapse or metastasis or locally advanced cancer or at least a second-line chemotherapy regimen. Patients self-rated FD and assessed symptoms, psychosocial distress, and QOL on validated questionnaires. Results: The average patient age was 59 years, and 144 (49%) were female. FD and high intensity were reported more frequently in U.S. patients than in French (respectively 129 [88%] vs. 74 [52%], p <.001; 100 [98%] vs. 48 [34%], p <.001,). QOL was rated higher by the U.S. patients than by the French (69 [SD, 18] vs. 63 [SD, 18], p =.003). French patients had more psychological symptoms such as anxiety (8 [SD, 4] vs. 6 [SD, 5], p =.008). Associations were found between FD and U.S. residence, FD and single status (0.907, p =.023), and FD and metastasis (1.538, p =.036). In contrast, negative associations were found between FD and older age (−0.052, p =.003) and FD and France residence (−3.376, p =.001). Conclusion: Regardless of health care system, FD is frequent in patients with advanced cancer. U.S. patients were more likely to have FD than French patients but reported better QOL. Further research should focus on factors contributing to FD and opportunities for remediation. Implications for Practice: Suffering is experienced in any component of the lives of patients with a life-threatening illness. Financial distress (FD) is one of the least explored cancer-related symptoms, and there are limited studies describing its impact on this frail population. This study highlights the high frequency and severity of FD in patients with advanced cancer in the U.S. and France as well as its impact on their physical and emotional symptoms and their quality of life in these different health care systems. It is necessary for all health care providers to explore and evaluate the presence of FD in patients living with life-threatening illnesses.
AB - Background: Financial distress (FD) is common among patients with advanced cancer. Our purpose was to compare the frequency and intensity of FD and its associations with symptom distress and quality of life (QOL) in these patients in France and the U.S. Materials and Methods: In this secondary analysis of two cross-sectional studies, we assessed data on 292 patients who received cancer care at a public hospital or a comprehensive cancer center in France (143 patients) or the U.S. (149 patients). Outpatients and hospitalized patients over 18 years of age with advanced lung or breast or colorectal or prostate cancer were included. Diagnosed cognitive disorder was considered a noninclusion criterion. Advanced cancer included relapse or metastasis or locally advanced cancer or at least a second-line chemotherapy regimen. Patients self-rated FD and assessed symptoms, psychosocial distress, and QOL on validated questionnaires. Results: The average patient age was 59 years, and 144 (49%) were female. FD and high intensity were reported more frequently in U.S. patients than in French (respectively 129 [88%] vs. 74 [52%], p <.001; 100 [98%] vs. 48 [34%], p <.001,). QOL was rated higher by the U.S. patients than by the French (69 [SD, 18] vs. 63 [SD, 18], p =.003). French patients had more psychological symptoms such as anxiety (8 [SD, 4] vs. 6 [SD, 5], p =.008). Associations were found between FD and U.S. residence, FD and single status (0.907, p =.023), and FD and metastasis (1.538, p =.036). In contrast, negative associations were found between FD and older age (−0.052, p =.003) and FD and France residence (−3.376, p =.001). Conclusion: Regardless of health care system, FD is frequent in patients with advanced cancer. U.S. patients were more likely to have FD than French patients but reported better QOL. Further research should focus on factors contributing to FD and opportunities for remediation. Implications for Practice: Suffering is experienced in any component of the lives of patients with a life-threatening illness. Financial distress (FD) is one of the least explored cancer-related symptoms, and there are limited studies describing its impact on this frail population. This study highlights the high frequency and severity of FD in patients with advanced cancer in the U.S. and France as well as its impact on their physical and emotional symptoms and their quality of life in these different health care systems. It is necessary for all health care providers to explore and evaluate the presence of FD in patients living with life-threatening illnesses.
KW - Advanced cancer
KW - Financial distress
KW - Palliative care
KW - Quality of life
KW - Symptom distress
UR - http://www.scopus.com/inward/record.url?scp=85062982917&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85062982917&partnerID=8YFLogxK
U2 - 10.1634/theoncologist.2018-0353
DO - 10.1634/theoncologist.2018-0353
M3 - Article
C2 - 30877191
AN - SCOPUS:85062982917
SN - 1083-7159
VL - 24
SP - 1121
EP - 1127
JO - Oncologist
JF - Oncologist
IS - 8
ER -